Results 41 to 50 of about 178 (95)

Predictors of post-COVID syndrome: opposing effects of arterial stiffness and targeted therapy in acute COVID-19

Рациональная фармакотерапия в кардиологии
Aim. To evaluate the impact of arterial stiffness and targeted therapy (biologic drugs and Janus kinase inhibitor) during the acute phase of coronavirus disease 2019 (COVID-19) on the risk of post-COVID syndrome (PCS).
V. I. Podzolkov, Ilya I. Shvedov, Nino A. Dzhaiani, Anna E. Bragina   +3 more
doaj   +1 more source

Extract of oak bark as a selective natural reagent for the spectrophotometric determination of iron (II) in pharmaceutical preparations and blood serum

Научно-практическая ревматология
Interleukin 6 (IL-6) plays a key role in the immunopathogenesis of rheumatoid arthritis (RA), with the pleiotropic effect on organs and tissues. Blocking IL-6 receptors is of interest both in terms of correcting joint syndrome and alleviating systemic ...
V. I. Mazurov, A. M. Lila, D. I. Abdulganieva, O. V. Antipova, I. B. Vinogradova, I. Z. Gaydukova, A. B. Demina, L. V. Eliseeva, E. S. Zhugrova, M. V. Zlobin, E. V. Zonova, A. A. Kastanayan, A. A. Klimenko, D. G. Krechikova, T. V. Kropotina, G. V. Lukina, O. B. Nesmeyanova, T. V. Plaksina, T. V. Povarova, E. V. Puntus, S. A. Smakotina, E. A. Smolyarchuk, V. N. Soboleva, N. F. Soroka, G. F. Fatkhullina, O. A. Tsyupa, S. P. Yakupova, A. A. Lutckii, A. V. Zinkina-Orikhan, Yu. N. Linkova, G. A. Vinderskaya, M. A. Morozova, J. V. Morkel, P. S. Pukhtinskaia, E. L. Nasonov   +34 more
doaj   +1 more source

Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review. [PDF]

Bionanoscience, 2022
Kirillova A, Lado A, Blatt N.
europepmc   +1 more source

Interleukin-6 blocking agents for treating COVID-19: a living systematic review. [PDF]

Cochrane Database Syst Rev, 2023
Ghosn L, Assi R, Evrenoglou T, Buckley BS, Henschke N, Probyn K, Riveros C, Davidson M, Graña C, Bonnet H, Jarde A, Ávila C, Nejstgaard CH, Menon S, Ferrand G, Kapp P, Breuer C, Schmucker C, Sguassero Y, Nguyen TV, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P, Chaimani A, Boutron I.   +28 more
europepmc   +1 more source

An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). [PDF]

Int Immunopharmacol, 2022
Elahi R, Karami P, Heidary AH, Esmaeilzadeh A.   +3 more
europepmc   +1 more source

Applying Lessons Learned From COVID-19 Therapeutic Trials to Improve Future ALI/ARDS Trials. [PDF]

Open Forum Infect Dis, 2022
Wu Q, Pennini ME, Bergmann JN, Kozak ML, Herring K, Sciarretta KL, Armstrong KL.   +6 more
europepmc   +1 more source

A Clinical Case of Nosocomial Pneumonia as a Complication of COVID-19: How to Balance Benefits and Risks of Immunosuppressive Therapy? [PDF]

Antibiotics (Basel), 2022
Rachina S, Kiyakbaev G, Antonova E, Mescheryakov A, Kupryushina O, Hewathanthirige G, Palagin I, Kozhevnikova E, Sukhorukova M, Strelkova D.   +9 more
europepmc   +1 more source

Inhalable antibodies for the treatment of COVID-19. [PDF]

Innovation (Camb), 2022
Yang Z, Li C, Song Y, Ying T, Wu Y.
europepmc   +1 more source

Coronavirus Infection COVID-19 and Pregnancy. [PDF]

Her Russ Acad Sci, 2022
Kurtser MA.
europepmc   +1 more source

Intensive Care of Patients with COVID-19. [PDF]

Her Russ Acad Sci, 2022
Petrikov SS, Popugaev KA, Zhuravel' SV.
europepmc   +1 more source